期刊文献+

国家重点监控药品合理用药管理规范 被引量:1

Rational use management standards of national key monitoring drug
下载PDF
导出
摘要 目前,国家重点监控药品的合理使用管理缺乏统一的规范。为使国家重点监控药品在各级医疗机构更加合理使用和规范管理,根据国家的相关要求和近年来国内外发布的相关文献,并结合全国多家医疗机构对国家重点监控药品的管理实践,由中华医学会临床药学分会、中国药学会药物流行病学专委会及四川省药学会药物流行病学专委会组织专家充分讨论,形成《国家重点监控药品合理用药管理规范》。本规范主要内容包括重点监控药品的合理使用基本原则及重点监控药品监管办法,特别是怎样加强重点监控药品的药事管理和使用管理,旨在推动重点监控药品的规范使用,促进合理用药。 At present,there is a lack of unified and standardized management for the rational use of national key monitoring drugs.According to the relevant requirements of the state,based on the relevant literature published at home and abroad in recent years and combined with the management practice of many medical institutions across the country on the national key monitoring drugs,in order to make the national key monitoring drugs more reasonable use and standardized management in medical institutions at all levels,the Clinical Pharmacy Branch of the Chinese Medical Association,the Pharmaceutical Epidemiology Special Committee of the Chinese Pharmaceutical Association and the Pharmaceutical Epidemiology Special Committee of the Sichuan Pharmaceutical Association organized experts to fully discuss,and to form this management standard.This standard mainly provides relevant opinions and suggestions on the basic principles of rational use of key monitoring drugs and the regulatory measures for key monitoring drugs,especially on how to strengthen the pharmaceutical management and use management of key monitoring drugs,further promoting the standardized use of key monitoring drugs.
作者 徐菲飞 边原 韩勇 闫峻峰 童荣生 XU Feifei;BIAN Yuan;HAN Yong;YAN Junfeng;TONG Rongsheng(Dept.of Pharmacy,Sichuan Academy of Medical Sciences&Sichuan Provincial People’s Hospital,Chengdu 610072,China;Personalized Drug Therapy Key Laboratory of Sichuan Province,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610072,China)
出处 《中国药房》 CAS 北大核心 2023年第19期2305-2310,共6页 China Pharmacy
基金 国家重点研发计划主动健康和老龄化科技应对重点专项(No.2020YFC2005500) 四川省自然科学基金项目(No.2022-NSFSC0818) 个体化药物治疗四川省重点实验室开放和自拟课题(No.2021YB10,No.2021ZD01)
关键词 重点监控药品 合理用药 管理规范 临床药师 key monitoring drugs reasonable drug use management standards clinical pharmacist
  • 相关文献

参考文献2

二级参考文献17

共引文献49

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部